Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04032366
Other study ID # INSTEAD
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 1, 2019
Est. completion date December 31, 2021

Study information

Verified date July 2019
Source Shanghai Zhongshan Hospital
Contact Zhe Luo, PhD
Phone 02164041990
Email ec@zs-hospital.sh.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study was to clarify the possible mechanism of hypoxemia after surgical treatment of type A acute aortic dissection and the possible mechanism of the treatment role of inhaled nitric oxide in refractory hypoxemia.


Description:

The investigators' previous study has stressed that inhaled nitric oxide therapy might play an ameliorative role in patients with refractory hypoxemia after surgical treatment of type A acute aortic dissection. The possible reason might be the decreasing of intrapulmonary shunt because previous studies showed that inhaled nitric oxide could decrease intrapulmonary shunt by selectively dilating the pulmonary vessels in ventilated areas. As a result, the investigators designed this observational study to calculate the intrapulmonary shunt before and after inhaled nitric oxide therapy. Intrapulmonary shunt was calculated from oxygen content (CO2) of different sites ( artery, mixed venous, alveolar capillary) by Fick equation:(CaO2-CcO2)/(CvO2-CcO2). A FiO2 of 1.0 and tidal volume of 6~8 ml/kg were chosen. Oxygen content was calculated from hemoglobin (Hb), oxygen saturation (SO2) and oxygen partial pressure (PO2) by the following equation: CO2 = 1.34*Hb*SO2 + 0,0031*PO2. PaO2, SaO2, PvO2 and SvO2 were measured from arterial and mixed venous blood samples taken from the radial arterial catheter and from the pulmonary artery catheter. ScO2 was estimated to be 1.0 with a FiO2 of 100%. PcO2 was considered to be the same as PAO2 (partial pressure of oxygen in the alveoli), and was calculated from the alveolar gas equation with PAO2 = [(atmospheric pressure - 47) * (FiO2)] - PaCO2/0.8.Other variables such as hemodynamic variables from pulmonary artery catheter were also collected.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date December 31, 2021
Est. primary completion date December 31, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Adult

- Type A aortic dissection;

- After surgery;

- P/F ratio = 200mmHg

Exclusion Criteria:

- Intracardiac shunt;

- Contradiction of PAC;

- Chronic pulmonary diseases before surgery;

- ECMO;

- Anticipation of death within 48 hours after operation;

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
inhaled nitric oxide
using of inhaled nitric oxide
Device:
PEEP
increasing PEEP or decreasing PEEP

Locations

Country Name City State
China Zhongshan hospital Fudan University Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Shanghai Zhongshan Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Intrapulmonary shunt with a PEEP of 5 cm H2O intrapulmonary shunt calculated by Fick equation with a PEEP of 5 cm H2O 6 to 24 hours after surgery
Primary Intrapulmonary shunt with a PEEP of 10 cm H2O intrapulmonary shunt calculated by Fick equation with a PEEP of 10 cm H2O 30 minutes after increasing PEEP to 10cm H2O
Primary Intrapulmonary shunt with a PEEP of 10 cm H2O and inhaled nitric oxide intrapulmonary shunt calculated by Fick equation with a PEEP of 10 cm H2O and inhaled nitric oxide 30 minutes after inhaling nitric oxide
Primary Intrapulmonary shunt with inhaled nitric oxide and a PEEP of 5 cm H2O intrapulmonary shunt calculated by Fick equation with inhaled nitric oxide and a PEEP of 5 cm H2O 30 minutes after decreasing PEEP to 5cm H2O
Secondary cardiac output collected from PAC with a PEEP of 5 cm H2O cardiac output in L/min 6 to 24 hours after surgery
Secondary pulmonary artery pressure collected from PAC with a PEEP of 5 cm H2O pulmonary artery pressure in mmHg 6 to 24 hours after surgery
Secondary pulmonary artery wedge pressure collected from PAC with a PEEP of 5 cm H2O pulmonary artery wedge pressure in mmHg 6 to 24 hours after surgery
Secondary cardiac output collected from PAC with a PEEP of 10cm H2O cardiac output in L/min 30 minutes after increasing PEEP to 10cm H2O
Secondary pulmonary artery pressure collected from PAC with a PEEP of 10 cm H2O pulmonary artery pressure in mmHg 30 minutes after increasing PEEP to 10cm H2O
Secondary pulmonary artery wedge pressure collected from PAC with a PEEP of 10 cm H2O pulmonary artery wedge pressure in mmHg 30 minutes after increasing PEEP to 10cm H2O
Secondary cardiac output collected from PAC with a PEEP of 10 cm H2O and inhaled nitric oxide cardiac output in L/min 30 minutes after inhaling nitric oxide
Secondary pulmonary artery pressure collected from PAC with a PEEP of 10 cm H2O and inhaled nitric oxide pulmonary artery pressure in mmHg 30 minutes after inhaling nitric oxide
Secondary pulmonary artery wedge pressure collected from PAC with a PEEP of 10 cm H2O and inhaled nitric oxide pulmonary artery wedge pressure in mmHg 30 minutes after inhaling nitric oxide
Secondary cardiac output collected from PAC with inhaled nitric oxide and a PEEP of 5 cm H2O cardiac output in L/min 30 minutes after decreasing PEEP to 5 cm H2O
Secondary pulmonary artery pressure collected from PAC with inhaled nitric oxide and a PEEP of 5 cm H2O pulmonary artery pressure in mmHg 30 minutes after decreasing PEEP to 5 cm H2O
Secondary pulmonary artery wedge pressure collected from PAC with inhaled nitric oxide and a PEEP of 5 cm H2O pulmonary artery wedge pressure in mmHg, etc 30 minutes after decreasing PEEP to 5 cm H2O
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06199401 - Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery N/A
Active, not recruiting NCT03369977 - BioGlue as an Adjunct for Structural Repair and Hemostasis in Chinese Acute Type A Aortic Dissections Patients N/A
Completed NCT05751200 - Safety and Efficacy of Aortic Root Reinforcement Combined With Vascular Grafts Eversion and built-in Procedure (XJ-procedure) in Patients With Acute Type A Aortic Dissection (ADVANCED-XJ )
Completed NCT04711889 - Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Ulinastatin) II N/A
Recruiting NCT03607786 - Antegrade Cerebral Perfusion and Retrograde Inferior Vena Caval Perfusion for Total Aortic Arch Replacement N/A
Completed NCT06415630 - Prediction Models for Postoperative Reintubation in Patients With Acute Aortic Dissection
Enrolling by invitation NCT05927090 - Outcomes of Type A Aortic Dissection Repair
Completed NCT05346497 - Surgical Management of the Aortic Root and Long-term Outcomes For Acute Type A Aortic Dissection
Active, not recruiting NCT04831073 - European Registry of Type A Aortic Dissection
Recruiting NCT06434987 - Impact of RIVP on GI Function in Patients Undergoing Surgical Repair for ATAAD
Completed NCT02164201 - Post Market Surveillance Study Evaluating BioFoam Surgical Matrix in Cardiovascular Surgery N/A